Immune checkpoint molecules such as PD‐1/PD‐L1, cytotoxic T lymphocyte‐associated protein 4 (CTLA‐4), and lymphocyte activation gene 3 are critical for tumor immune evasion, and emerging evidence highlights signaling crosstalk between TLRs and these inhibitory pathways [78]. Here, CD274 is linked to neoplasm.